| Nordic Resources Limited (NNL) ORDINARY FULLY PAID |
Materials |
$68 |
Change in substantial holding
|
24 Mar 2026 8:20AM |
$0.125 |
$0.180 |
risen by
44%
|
|
| Reliance Worldwide Corporation Limited (RWC) ORDINARY FULLY PAID |
Industrials |
$2,326 |
Update - Notification of buy-back - RWC
|
24 Mar 2026 8:20AM |
$3.030 |
$3.110 |
risen by
2.64%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$157 |
Dividend/Distribution - CLV
|
24 Mar 2026 8:20AM |
$0.745 |
$0.940 |
risen by
26.17%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,776 |
Net Tangible Asset Backing
|
24 Mar 2026 8:19AM |
$3.660 |
$4.380 |
risen by
19.67%
|
|
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$23,592 |
Update - Dividend/Distribution - AAI
|
24 Mar 2026 8:19AM |
$79.840 |
$89.410 |
risen by
11.99%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,486 |
Update - Notification of buy-back - KAR
|
24 Mar 2026 8:19AM |
$2.060 |
$2.090 |
risen by
1.46%
|
|
| Perpetual Limited (PPT) ORDINARY FULLY PAID |
Financials |
$1,874 |
Change in substantial holding
|
24 Mar 2026 8:19AM |
$16.100 |
$16.200 |
risen by
0.62%
|
|
| Treasury Wine Estates Limited (TWE) ORDINARY FULLY PAID |
Consumer Staple |
$3,432 |
Ceasing to be a substantial holder
|
24 Mar 2026 8:19AM |
$3.570 |
$4.250 |
risen by
19.05%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$157 |
Clover 1H FY26 Investor Presentation
|
24 Mar 2026 8:19AM |
$0.745 |
$0.940 |
risen by
26.17%
|
|
CLV - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross margin improved due to favorable customer and product mix.
- Operating costs increased to support growth.
- NPAT result of $4.2m, up from $2.4m in 1H FY25.
- Cash flow impacted by inventory build of oils against strong forecasts.
- Revenue growth driven by new customer acquisitions and product mix.
- Balance sheet remains strong with $10.3m cash and nil bank debt.
- CholineXcel® being tested for packaging and shelf-life.
- DHA and ARA growth supported by product diversification.
- Ecuador facility provides consistent supply for tuna oil requirements.
- FY26 revenue guidance is between $92 to $96m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$157 |
Clover 1H FY26 Results Announcement
|
24 Mar 2026 8:19AM |
$0.745 |
$0.940 |
risen by
26.17%
|
|
CLV - Price-sensitive ASX Announcement
Full Release
Key Points
- Clover Corporation reported a strong performance for the first half of FY26 with revenue of $44.1 million, a significant increase from $37.6 million in 1H FY25.
- The company's gross margin improved to 35.6%, an 850 basis point increase from the previous year.
- Clover's EBITDA rose to $6.9 million, up from $4.3 million in the same period last year.
- Net Profit After Tax (NPAT) increased to $4.2 million compared to $2.4 million in 1H FY25.
- Clover's Board declared a fully franked interim dividend of 1.0 cent per share.
- The company is actively expanding its product portfolio and market reach, particularly in human nutrition segments including seniors, toddlers, and adult nutrition.
- Strategic investments and collaborations, such as with Melody Dairies and tuna oil extraction in Ecuador, are contributing to Clover's growth and diversification.
- Clover is working on the registration and approval of its DHA emulsion, Premneo, across various global markets.
- The revenue guidance for FY26 is projected between $92 and $96 million.
- Clover continues to innovate with new products like CholineXcel® and diversified DHA formulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$195 |
Update - Notification of buy-back - CAA
|
24 Mar 2026 8:19AM |
$10.870 |
$12.190 |
risen by
12.14%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$157 |
Clover 1H FY26 Report and Accounts
|
24 Mar 2026 8:19AM |
$0.745 |
$0.940 |
risen by
26.17%
|
|
CLV - Price-sensitive ASX Announcement
Full Release
Key Points
- Clover Corporation reported a 17% revenue increase to $44.1 million for 1H FY26.
- Net profit after tax rose by 90% to $4.2 million.
- EBITDA improved to $6.9 million due to strategic initiatives.
- The company is focusing on product diversification and market expansion.
- An interim dividend of 1.00 cent per share was declared.
- Revenue projection for FY26 is between $92 to $96 million.
- Operational improvements included enhanced manufacturing efficiencies.
- Clover continues to innovate with new product solutions such as non-allergenic powders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$4,550 |
Becoming a substantial holder
|
24 Mar 2026 8:19AM |
$0.720 |
$0.930 |
risen by
29.17%
|
|
| SEEK Limited (SEK) ORDINARY FULLY PAID |
Communication Services |
$4,772 |
Ceasing to be a substantial holder
|
24 Mar 2026 8:18AM |
$14.670 |
$13.360 |
fallen by
8.93%
|
|
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,305 |
Becoming a substantial holder
|
24 Mar 2026 8:18AM |
$3.090 |
$3.330 |
risen by
7.77%
|
|
| Desert Metals Limited (DM1) ORDINARY FULLY PAID |
Materials |
$7 |
Commences 2,000m aircore drilling at Tiogo gold prospect
|
24 Mar 2026 8:18AM |
$0.007 |
$0.010 |
risen by
42.86%
|
|
DM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Desert Metals initiated a 2,000m aircore drilling program at Tiogo.
- Targeting a 900m untested corridor between previous high-grade intercepts.
- Phase 1 is part of a larger 6,000m drilling program in 2026.
- The drilling program is expected to complete in two weeks.
- Results expected in April 2026, with assays through Chrysos PhotonAssay.
- Tiogo is located 30km from Perseus Mining’s Sissingué gold mine.
- GAIP survey confirmed a +4km anomaly at Tiogo.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$6,478 |
Update - Notification of buy-back - DNL
|
24 Mar 2026 8:18AM |
$2.910 |
$3.690 |
risen by
26.80%
|
|
| Battery Age Minerals Ltd (BM8) ORDINARY FULLY PAID |
Materials |
$16 |
BM8 Unlocks Critical Metals Potential at Bleiberg
|
24 Mar 2026 8:18AM |
$0.064 |
$0.070 |
risen by
9.38%
|
|
BM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Battery Age Minerals Ltd has commenced a maiden drilling program in the historic Bleiberg mining district, confirming a zinc-lead-germanium system.
- Higher-grade mineralization was identified at the Rubland target, including 2.5m @ 3.96% Zn+Pb.
- The exploration program consisted of six diamond drill holes totaling 1,685 meters across the Rubland and Tschöklnock targets.
- The company aims to focus future exploration on historically productive areas within the Bleiberg complex.
- Battery Age Minerals plans to engage with local stakeholders to align with the European Union’s Critical Raw Materials Act framework.
- The Bleiberg district is historically significant with approximately 700 years of mining activity, previously known for high-grade germanium concentrates.
- The company currently holds a 51% interest in the Bleiberg JV, with potential to increase to 80% by completing further expenditure and feasibility studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ama Group Limited (AMA) ORDINARY FULLY PAID |
Industrials |
$258 |
Change of Director's Interest Notices
|
24 Mar 2026 8:18AM |
$0.530 |
$0.535 |
risen by
0.94%
|
|
| Stepchange Holdings Limited (STH) ORDINARY FULLY PAID |
Information Technology |
$25 |
Update - Notification of buy-back - STH
|
24 Mar 2026 8:18AM |
$0.110 |
$0.150 |
risen by
36.36%
|
|
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$6 |
Letter to Ineligible Shareholders
|
24 Mar 2026 8:18AM |
$0.006 |
$0.004 |
fallen by
27.27%
|
|
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$6 |
Letter to Eligible Shareholders
|
24 Mar 2026 8:18AM |
$0.006 |
$0.004 |
fallen by
27.27%
|
|
| Emmerson Resources Limited (ERM) ORDINARY FULLY PAID |
Materials |
$260 |
Minimum Production Payment Update
|
24 Mar 2026 8:18AM |
$0.320 |
$0.390 |
risen by
21.88%
|
|
ERM - Price-sensitive ASX Announcement
Full Release
Key Points
- Emmerson Resources Limited has invoiced Tennant Consolidated Mining Group $10.53 million for the Minimum Production Payment.
- The payment is related to the Northern Project Area of Emmerson's Small Mines Joint Venture.
- Payment will be received in three equal installments in April, May, and June 2026.
- The Southern Project Area's MPP, influenced by gold price movements, will be invoiced in late May 2026.
- Emmerson Resources has entered an agreement with Pan African Resources to be acquired via an Australian scheme of arrangement.
- Emmerson shareholders will receive 0.1493 PAN shares for each Emmerson share as part of the scheme.
- The Emmerson board recommends shareholders vote in favor of the acquisition scheme.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$6 |
Non-renounceable Entitlement Offer Opens
|
24 Mar 2026 8:17AM |
$0.006 |
$0.004 |
fallen by
27.27%
|
|
| American Uranium Limited (AMU) ORDINARY FULLY PAID |
Materials |
$12 |
Appendix 4G & Corporate Governance Statement
|
24 Mar 2026 8:17AM |
$0.113 |
$0.094 |
fallen by
16.44%
|
|
Call 1300 880 160
Start a chat
Schedule a call
